changing from tirzepatide to retatrutide vs. Retatrutide: Key Differences Explained How to switch from Tirzepatide

The duration of dose escalation employed to reach the target dose of tirzepatide in the SURPASS trial was longer (020 weeks) than the corresponding durations used for the comparators in the comparator studies (08 weeks), contributing to a source of heterogeneity between trials

GLP-1 : From Diabetes Management to Weight Loss Both Ozempic (the brand name for Novo Nordisks drug semaglutide) and Mounjaro (the brand name for Eli Lillys drug tirzepatide) are GLP-1 (glucagon-like peptide-1) agonists originally designed to help people with Type 2 diabetes

Zepbound is an FDA-approved dual GIP/GLP-1 receptor agonist for chronic weight management that typically produces significant weight loss

Slightly nauseous, first week no significant weight loss, but 2nd & 3rd wk 3 lbs each